Compound ID | 546
Synonym(s): PD 131112 (Prodrug of PD 131628) | PD 131628
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Mice infected with P. aeruginosa were treated with a number of different quinolones. 50 of 60 mice recovered with the treatment of CI-990 whereas 54 of 60 mice recovered from lomefloxacin; more active against Gram positives than Gram negatives; more active against Gram positives than Gram negatives |
| Description: | Brook I and Ledney GD. Quinolone therapy in the prevention of endogenous and exogenous infection after irradiation. 32nd-Intersci-Conf-Antimicrobial-Agents-Chemother 1992; 239. |
| Institute where first reported: | Pfizer, USA; Parke-Davis Pharmaceutical |
| Year first mentioned: | 1990 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| Reason Dropped: | Most of the early potent Gram positive favoring fluoroquinolones showed genotoxicity (LS) |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/72448 |
| Citations: |
|